Market Place
Sourcing Support
Achillion gets $15M milestone payment from Janssen for advancement of HCV drug
29 Dec 2016 //
PHARMABIZ
EU Health Regulator Warns Some Hep C Drugs Could Reactivate Hep B
03 Dec 2016 //
REUTERS
Recent Success in HCV Treatment Brings Relief to Patients
07 Nov 2016 //
DRUG DEVELOPMENT
Japan`s PMDA reviews hep B risk link to hep C therapies
04 May 2016 //
FIERCE ASIA
EU extends safety review of chronic Hep C treatments
15 Apr 2016 //
REUTERS
Switching study gives Celltrion biosim more ammo in fight for Remicade share
21 Mar 2016 //
FIERCE PHARMA MARKETING
J&J chief Gorsky suffers cuts in bonus, incentive pay, but still racks up $23.8M
17 Mar 2016 //
FIERCE PHARMA
Regulus hep C combo drug effective in mid-stage study
18 Feb 2016 //
REUTERS
J&J`s new launches deliver, but overall sales fall short on hep C, strong dollar
26 Jan 2016 //
FIERCE PHARMA
More formulary exclusion are on their way as smaller PBMs get in the action
02 Dec 2015 //
FIERCE PHARMA
Gilead, AbbVie Asked by U.S. for Hepatitis C Pricing Options
06 Nov 2015 //
BLOOMBERG
Will the J&J Deal With Achillion Transform the Hep C Market?
21 May 2015 //
PHARMALOT
J&J promises new uses for old meds to keep pharma sales flying high
20 May 2015 //
FIERCE PHARMA
AbbVie moves closer to Japan`s crowded hep C field with priority review nod
17 Apr 2015 //
FIERCE PHARMA
Johnson & Johnson Profit Tops Estimates as Drug Sales Rise
15 Apr 2015 //
BLOOMBERG BUSINESS
Sovaldi pushes Gilead to the top of US pharma list
15 Apr 2015 //
PM LIVE
Why Did Prescription Drug Spending Hit $374B in the US Last Year? Read This
15 Apr 2015 //
PHARMALOT
Currency hurts, Olysio plummets, but J&J pharma growth carries on
14 Apr 2015 //
FIERCE PHARMA
Gilead Under Fire for Sovaldi Anti-Diversion Policy
13 Apr 2015 //
PMLIVE
Gilead’s $1,000 Pill Is Hard for States to Swallow
10 Apr 2015 //
THE WALL STREET JOURNAL
J&J Chief Predicts 10 New Pharma Filings By 2017
21 Jan 2015 //
PMLIVE
Janssen Agrees to Rebate Cost of Olysio to England`s NHS if it Doesn`t Work
16 Jan 2015 //
FIERCE PHARMA
Gilead to Appeal India Patent Ruling on Niche Sovaldi Claim
16 Jan 2015 //
FIERCE PHARMA
NICE Backs New Hepatitis C Treatments
16 Jan 2015 //
PMLIVE
Janssen Offers NHS to Pay for Olysio Failures
16 Jan 2015 //
PHARMABIZ
Get Ready to Negotiate, Drugmakers: Payers are Armed for Drug-Pricing Battle
24 Dec 2014 //
FIERCE PHARMA
CA Panel: Gilead`s Harvoni Cost-Effective At $95K, But Only Affordable At Half the Price
15 Dec 2014 //
FIERCEPHARMA
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead`s Hepatitis-C Drug Sovaldi
09 Dec 2014 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.